Evidence map›Paper›PMID 40822978›Full record

ArticleProceedings. IEEE International Symposium on Biomedical Imaging2025

PLASMA-CYCLEGAN: PLASMA BIOMARKER-GUIDED MRI TO PET CROSS-MODALITY TRANSLATION USING CONDITIONAL CYCLEGAN.

Yanxi Chen, Yi Su, Celine Dumitrascu, Kewei Chen, David Weidman, Richard J Caselli, Nicholas Ashton, Eric M Reiman, Yalin Wang

Abstract read
In one paragraph

Article in Proceedings. IEEE International Symposium on Biomedical Imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yanxi ChenSchool of Computing and Augmented Intelligence, Arizona State University, Tempe, AZ.
Yi SuBanner Alzheimer's Institute, Phoenix, AZ, USA.
Celine DumitrascuBasis Scottsdale, Scottsdale, AZ, USA.
Kewei ChenCollege of Health Solutions, Arizona State University, Tempe, AZ, USA.
David WeidmanBanner Alzheimer's Institute, Phoenix, AZ, USA.
Richard J CaselliDepartment of Neurology, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Nicholas AshtonBanner Alzheimer's Institute, Phoenix, AZ, USA.
Eric M ReimanBanner Alzheimer's Institute, Phoenix, AZ, USA.
Yalin WangSchool of Computing and Augmented Intelligence, Arizona State University, Tempe, AZ.

Funding

APOE in the Predisposition to, Protection from and Prevention of Alzheimer's DiseaseR01AG069453 · NIA · BANNER HEALTH · PI ASHTON, NICHOLAS, LANGBAUM, JESSICA BROOKE · 2020 to 2025
$27.4M
Research Education ComponentP30AG072980 · NIA · BANNER HEALTH · PI Nicholas Ashton · 2021 to 2026
$24.9M
Tracer harmonization for amyloid and tau PET imaging using statistical and deep learning techniquesRF1AG073424 · NIA · BANNER HEALTH · PI SU, YI · 2022 to 2022
$2.3M
Tracer harmonization for amyloid and tau PET imaging using statistical and deep learning techniquesR01AG073424 · NIA · BANNER HEALTH · PI Yi Su · 2025 to 2026
$1.4M
Hierarchical Bayesian Analysis of Retinotopic Maps of the Human Visual Cortex with Conformal GeometryR01EY032125 · NEI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI LU, ZHONG-LIN, WANG, YALIN · 2021 to 2024
$1.2M
Developing a Univariate Neurodegeneration Imaging Biomarker with Optimal TransportationR21AG065942 · NIA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI WANG, YALIN · 2020 to 2020
$445k
NEI NIH HHS R01 EY032125NIA NIH HHS P30 AG072980NIA NIH HHS R01 AG069453NIA NIH HHS R01 AG073424NIA NIH HHS R21 AG065942NIA NIH HHS RF1 AG073424
6 · The paper itself

Abstract

Cross-modality translation between MRI and PET imaging is challenging due to the distinct mechanisms underlying these modalities. Blood-based biomarkers (BBBMs) are revolutionizing Alzheimer's disease (AD) detection by identifying patients and quantifying brain amyloid levels. However, the potential of BBBMs to enhance PET image synthesis remains unexplored. In this paper, we performed a thorough study on the effect of incorporating BBBM into deep generative models. By evaluating three widely used cross-modality translation models, we found that BBBMs integration consistently enhances the generative quality across all models. By visual inspection of the generated results, we observed that PET images generated by CycleGAN exhibit the best visual fidelity. Based on these findings, we propose Plasma-CycleGAN, a novel generative model based on CycleGAN, to synthesize PET images from MRI using BBBMs as conditions. This is the first approach to integrate BBBMs in conditional cross-modality translation between MRI and PET.

Indexed as

Blood-based biomarkersCross-modality translationCycleGANMRIPET

Identifiers

PMID40822978
PMCPMC12352453

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.